Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Breath carbon dioxide test to help detect pulmonary hypertension

Tests a breath carbon dioxide measurement in adults suspected of having pulmonary hypertension.

Plain-language title generated from the registry record
Registry title: Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension

Key facts

Where
Giessen, GermanySee the site

Where in Germany

  • University Clinic Giessen and MarburgGiessen, GermanyNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Giessen
Trial code
NCT03388476
Record updated
19 May 2022
Original description
Measurement of the endtidal carbon dioxide by capnography to exclude or to ensure the diagnosis pulmonary hypertension. The aim of the study is to obtain an endtidal carbon dioxide cut-off value for the diagnostic algorithm for pulmonary hypertension as an easily measurable and cheap diagnostic tool in patients with suspicion of pulmonary hypertension.Read full original descriptionShow less

Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension in Patients With Suspicion of Pulmonary Hypertension

Measurement of the endtidal carbon dioxide by capnography to exclude or to ensure the diagnosis pulmonary hypertension. The aim of the study is to obtain an endtidal carbon dioxide cut-off value for the diagnostic algorithm for pulmonary hypertension as an easily measurable and cheap diagnostic tool in patients with suspicion of pulmonary hypertension.

Inclusion: Age > 18 years, suspicion of pulmonary hypertension, planned or accomplished right heart catheterization.

Exclusion: none.

ClinicalTrials.gov NCT03388476